+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Asia-Pacific Allergy Treatment Market Outlook, 2030 - Product Thumbnail Image

Asia-Pacific Allergy Treatment Market Outlook, 2030

  • Report
  • August 2025
  • 96 Pages
  • Asia Pacific
From
Middle East and Africa Allergy Treatment Market Outlook, 2030 - Product Thumbnail Image

Middle East and Africa Allergy Treatment Market Outlook, 2030

  • Report
  • August 2025
  • 81 Pages
  • Africa, Middle East
From
Europe Allergy Treatment Market Outlook, 2030 - Product Thumbnail Image

Europe Allergy Treatment Market Outlook, 2030

  • Report
  • August 2025
  • 100 Pages
  • Europe
From
North America Allergy Treatment Market Outlook, 2030 - Product Thumbnail Image

North America Allergy Treatment Market Outlook, 2030

  • Report
  • August 2025
  • 89 Pages
  • North America
From
Allergic Rhinitis Drugs Market Report 2024-2034 - Product Thumbnail Image

Allergic Rhinitis Drugs Market Report 2024-2034

  • Report
  • February 2024
  • 322 Pages
  • Global
From
HIV Drugs and Injectables Market Report 2024-2034 - Product Thumbnail Image

HIV Drugs and Injectables Market Report 2024-2034

  • Report
  • July 2024
  • 288 Pages
  • Global
From
Allergy Immunotherapy Market Report 2023-2033 - Product Thumbnail Image

Allergy Immunotherapy Market Report 2023-2033

  • Report
  • May 2023
  • 187 Pages
  • Global
From
Masked Antibodies & Cytokines as Prodrugs: A Landscape Analysis of Stakeholders, Technologies, Pipelines, Business and Financing from An Industry Perspective - Product Thumbnail Image

Masked Antibodies & Cytokines as Prodrugs: A Landscape Analysis of Stakeholders, Technologies, Pipelines, Business and Financing from An Industry Perspective

  • Report
  • October 2021
  • 433 Pages
  • Global
From
Pipeline of Interleukin-6 (IL-6) Receptor Antagonists and IL6- Inhibitors - Product Thumbnail Image

Pipeline of Interleukin-6 (IL-6) Receptor Antagonists and IL6- Inhibitors

  • Report
  • November 2025
  • Global
From
Pipeline of Complement C5 Inhibitors & C5 Receptor Antagonists - Product Thumbnail Image

Pipeline of Complement C5 Inhibitors & C5 Receptor Antagonists

  • Report
  • November 2025
  • Global
From
Pipeline of PD-L1 x 4-1BB (CD137) Bispecific Antibodies - Product Thumbnail Image

Pipeline of PD-L1 x 4-1BB (CD137) Bispecific Antibodies

  • Report
  • November 2025
  • Global
From
Vectorized Antibodies for In Vivo Expression by DNA and mRNA: A Landscape Analysis Of Stakeholders, Technologies, Targets, Business and Financing from an Industry Perspective - Product Thumbnail Image

Vectorized Antibodies for In Vivo Expression by DNA and mRNA: A Landscape Analysis Of Stakeholders, Technologies, Targets, Business and Financing from an Industry Perspective

  • Report
  • July 2021
  • 259 Pages
  • Global
From
Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin): Insights & Forecast with Potential Impact of COVID-19 (2024-2028) - Product Thumbnail Image

Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)

  • Report
  • June 2024
  • 76 Pages
  • Global
From
Global Systemic Lupus Erythematosus (SLE) Market (by Product Type, Route of Administration, End User, & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026) - Product Thumbnail Image

Global Systemic Lupus Erythematosus (SLE) Market (by Product Type, Route of Administration, End User, & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

  • Report
  • September 2023
  • 135 Pages
  • Global
From
Neuroscience Antibodies & Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

Neuroscience Antibodies & Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • May 2024
  • 182 Pages
  • Global
From
CD137 Antibodies Clinical Trials & Market Opportunity Insight - Product Thumbnail Image

CD137 Antibodies Clinical Trials & Market Opportunity Insight

  • Report
  • September 2024
  • 210 Pages
  • Global
From
Anti TIGIT Antibodies Clinical Trials & Market Opportunity Outlook 2028 - Product Thumbnail Image

Anti TIGIT Antibodies Clinical Trials & Market Opportunity Outlook 2028

  • Report
  • August 2024
  • 195 Pages
  • Global
From
Global CD3 Antibodies Market, Dosage, Price, Sales & Clinical Trials Insight 2028 - Product Thumbnail Image

Global CD3 Antibodies Market, Dosage, Price, Sales & Clinical Trials Insight 2028

  • Report
  • October 2023
  • 470 Pages
  • Global
From
China Bispecific Antibodies Market and Clinical Pipeline Insight 2028 - Product Thumbnail Image

China Bispecific Antibodies Market and Clinical Pipeline Insight 2028

  • Drug Pipelines
  • August 2023
  • 400 Pages
  • China
From
US Bispecific Antibodies Market & Clinical Pipeline Insight 2028 - Product Thumbnail Image

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

  • Drug Pipelines
  • August 2023
  • 580 Pages
  • United States
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more